US FDA Tech Modernization Plan’s Costs Uncertain
Agency officials determining needs using existing budgets before requesting more funds and will engage with tech investors for design advice.
You may also be interested in...
President Trump's budget request would boost compounding and vaccines by $5m, but human drugs program would lose $4.8m in training funds.
The Center for Biologics Evaluation and Research may need more fee revenue to add employees to handle the increasing cell and gene therapy workload.
FDA seeks expert comments during an upcoming public meeting on strategies to facilitate various centers combining and sharing data.